Antimicrobial therapy of urinary tract infections in children

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Pharmacology

Background:

• Childhood urinary tract infections (UTIs) require prompt management to prevent severe outcomes such as urosepsis and renal scarring.
• Antibiotic resistance patterns in uropathogens vary geographically, necessitating localized treatment strategies.
• Increasing resistance to ampicillin and trimethoprim/sulfamethoxazole (TMP/SMX) has been observed over the past two decades.

Purpose of the Study:

• To outline key objectives in managing childhood UTIs, focusing on rapid recovery and complication prevention.
• To emphasize the importance of considering local antimicrobial resistance data when prescribing antibiotics for UTIs.
• To provide guidance on age- and severity-dependent antibiotic selection for pediatric UTIs.

Main Methods:

• Review of current therapeutic recommendations for childhood urinary tract infections.
• Analysis of regional trends in bacterial resistance, particularly for common uropathogens like Escherichia coli.
• Consideration of factors influencing antibiotic choice, including patient age, clinical presentation, and complicating factors.

Main Results:

• Relatively low resistance rates for cephalosporins, aminoglycosides, nitrofurantoin, and quinolones against Escherichia coli.
• Significant increase in resistance rates for ampicillin and TMP/SMX in Escherichia coli over the last 20 years.
• Specific first-line antibiotic recommendations for pyelonephritis based on infant age (e.g., aminoglycoside/ampicillin or ceftazidime/ampicillin for early infancy).

Conclusions:

• Effective management of childhood UTIs hinges on rapid symptom resolution, prevention of urosepsis, and avoidance of renal damage.
• Antibiotic therapy must be guided by local antimicrobial susceptibility data, with a shift away from ampicillin and TMP/SMX due to rising resistance.
• Treatment strategies vary by age, with early infancy requiring inpatient care and specific parenteral antibiotic combinations, while older children may receive oral cephalosporins.